BRCA1 positive
|
Prostate Cancer
|
BRCA1 positive
|
Prostate Cancer
|
olaparib Sensitive: B - Late Trials
|
olaparib Sensitive: B - Late Trials
|
BRCA1 positive
|
Cervical Cancer
|
BRCA1 positive
|
Cervical Cancer
|
bevacizumab + olaparib Sensitive: C4 – Case Studies
|
bevacizumab + olaparib Sensitive: C4 – Case Studies
|